Christian S Schade insider trades

Open-market stock purchases and sales by Christian S Schade, Director at Integra Lifesciences Holdings Corp, from SEC Form 4 filings since Mar 29, 2010.

Track record: 33% of 3 scored buys are up 5% or more since purchase, averaging -58%.

Recent trades

DateStockTradeValue
May 7, 2026IART Integra Lifesciences Holdings CorpBought (not open market)—

Companies traded

  • IART Integra Lifesciences Holdings Corp: 4 sales, last May 7, 2026
  • OMGA Omega Therapeutics, Inc: other filings, last Jun 20, 2024
  • APRE Aprea Therapeutics, Inc: 3 buys, last Jul 28, 2022
  • OMTH Omthera Pharmaceuticals, Inc: other filings, last Jul 18, 2013
  • NRG NRG Energy, Inc: other filings, last Mar 29, 2011

Get free alerts when Christian S Schade files a new trade →